Shares of American Tower (AMT) were raised to an overweight rating by a major sell side firm Tuesday with a $285 price target. AMT is a very large, global real estate investment trust with an attractive yield.




Shares of American Tower (AMT) were raised to an overweight rating by a major sell side firm Tuesday with a $285 price target. AMT is a very large, global real estate investment trust with an attractive yield.
Bulls hoped that a bottom had been found, but they overlooked the reasons behind the rally last week.
The shares have been in the single digits since early May.
With an expected dip for 2023, the pharmaceutical company could see its mRNA technology win big over the long term -- and investors could be rewarded.
Let's check out the charts and indicators on this operator of casinos and racetracks.
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login